Meritxell Vinyoles

6PUBLICATIONS
74CO-AUTHORS
Haematological tumoursMedical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 25, 2026
NG2-ITGA4 axis regulates Rho GTPases and leukemic aggressiveness in KMT2A-r B-ALL and is targetable with natalizumab.

|Mar 16, 2025
A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia.

Aïda Falgàs, Rodrigo Lázaro-Gorines, Samanta Romina Zanetti

|Aug 02, 2024
NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLLr B-ALL by regulating NR3C1 expression.

Belén Lopez-Millan, Alba Rubio-Gayarre, Meritxell Vinyoles

|Mar 04, 2024
CD155/PVR determines acute myeloid leukemia targeting by Delta One T cells.

Sofia Mensurado, Carolina Condeço, Diego Sánchez-Martínez

|Jan 04, 2024
Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression.

Oscar Molina, Carmen Ortega-Sabater, Namitha Thampi

|Sep 27, 2023
A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features.

Clara Bueno, Raul Torres-Ruiz, Talia Velasco-Hernandez

Pageof 1

Frequent Collaborators

4 joint publications

Clara Bueno

4 joint publications

Narcís Fernández-Fuentes

4 joint publications

Talia Velasco-Hernandez

4 joint publications

Pablo Menéndez